Eight months since the tax cuts were passed in December 2017, here’s what the data show: Corporate profits up, corporate tax revenues down (Figure 1): In the second quarter of 2018 (six months after the tax cuts passed in December 2017), corporate after-tax profits were 16% higher than a year earlier in the second quarter […]

Medicare & Medicare 53rd Anniversary National and State-by-State reports

Our national and state-by-state reports about Medicare and Medicaid, in honor of its 53rd Anniversary. National Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York […]

The Pharma Big 10: Price Gougers, Tax Dodgers

View the Full Report in PDF here. TOPLINES The report examines the profits, taxes, and drug prices of the 10 biggest U.S. pharmaceutical companies, the “Pharma Big 10”: Johnson & Johnson, Pfizer, Merck & Co., Gilead Sciences, AbbVie, Amgen, Eli Lilly & Co., Bristol-Myers Squibb, Biogen and Celgene. Between 2011 and 2015, the Pharma Big 10 […]

Gilead Sciences: Price Gouger, Tax Dodger

Press Release: New Report: Taxpayer-Supported Gilead Sciences Is Price Gouging the Public, Then Dodging Taxes on the Huge Profits 7/13/2016 ATF Report Highlights: Gilead Sciences: Prices Gouger, Tax Dodger 7/13/2016 Full Report in PDF 7/13/2016 Shareable graphics on the Gilead report click here. Irish Media Confirms ATF Claims About Gilead Science’s Massive Profit Shifting 8/22/2016 Huffington Post Piece on […]

Pfizer: Price Gouger, Tax Dodger

Pfizer, one of the world’s largest pharmaceutical companies and more profitable companies, is attempting to permanently dodge tens of billions of dollars of U.S. taxes it currently owes through a merger with fellow drug firm Allergan, based in the tax haven of Ireland. While technically not a corporate inversion, this maneuver will provide Pfizer with […]

Pfizer’s Tax Dodging Rx: Stash Profits Offshore

Pfizer, one of the world’s largest pharmaceutical companies, has announced that it has entered into preliminary discussions with the Irish corporation Allergan to effect a business combination, which most observers assume would be structured as an “inversion” transaction. An inversion would allow Pfizer to renounce its U.S. tax citizenship while retaining its current U.S. headquarters, management structure […]

The Walmart Web

How the World’s Biggest Corporation Secretly Uses Tax Havens to Dodge Taxes A groundbreaking report reveals that Walmart has built a vast, undisclosed network of 78 subsidiaries and branches in 15 overseas tax havens, which may be used to minimize foreign taxes where it has retail operations and to avoid U.S. tax on those foreign […]

The Walmart Tax Subsidy

As Walmart prepares to implement its previously announced plan to hike wages to a minimum of $9 an hour in April, Americans for Tax Fairness has published a new report detailing how employee wage hikes to $9 in 2015 and to $10 in 2016 will still require large taxpayer subsidies to compensate for Walmart’s low […]

Burger King’s Inversion: A Whopper of a Tax Dodge

This new Americans for Tax Fairness report shows that Burger King and its leading shareholders will dodge an estimated $400 million to $1.2 billion in taxes between 2015 and 2018 from its planned merger with Tim Hortons, a Canadian company. This contradicts the assertion by CEO Daniel Schwartz that Burger King’s plan to become a Canadian […]

New Report Reveals That Walmart Avoids Billions In U.S. Taxes, And Is Working To Change The Law So It Can Dodge Billions More

WASHINGTON – A new report released Thursday by Americans for Tax Fairness (ATF) reveals that Walmart uses tax breaks to dodge a whopping $1 billion annually, on average, in federal taxes. It also shows how Walmart is working behind the scenes to help lower the U.S. corporate tax rate to 25%, which would allow Walmart to cut its tax bill on average another […]